---

2014

ルーム内検索
全51件   1  2  3 次の20件>>
ID
トピック名
閲覧/投稿
最新投稿
作成
213 【基礎研究】Exosomal miR-135b shed from hypoxic multiple myeloma cells enhances angiogenesis by targeting factor-inhibiting HIF-1. 279 / 0
2015-09-28
KMF CRC
212 【レビュー】How I treat smoldering multiple myeloma. 299 / 0
2015-09-28
KMF CRC
211 【レビュー】Curing myeloma at last: defining criteria and providing the evidence. 308 / 0
2015-09-28
KMF CRC
210 【基礎研究】Differential and limited expression of mutant alleles in multiple myeloma. 354 / 0
2015-09-28
KMF CRC
209 【基礎研究】Investigating osteogenic differentiation in multiple myeloma using a novel 3D bone marrow niche model. 278 / 0
2015-09-28
KMF CRC
208 【基礎研究】Pyk2 promotes tumor progression in multiple myeloma. 286 / 0
2015-09-28
KMF CRC
207 【基礎研究】A Bim-targeting strategy overcomes adaptive bortezomib resistance in myeloma through a novel link between autophagy and apoptosis. 296 / 0
2015-09-28
KMF CRC
206 【基礎研究】Inhibition of sphingosine kinase 2 downregulates the expression of c-Myc and Mcl-1 and induces apoptosis in multiple myeloma. 305 / 0
2015-09-28
KMF CRC
205 【レビュー】GEM2005 trial update comparing VMP/VTP as induction in elderly multiple myeloma patients: do we still need alkylators? 325 / 0
2015-09-28
KMF CRC
204 【基礎研究】CXCR7-dependent angiogenic mononuclear cell trafficking regulates tumor progression in multiple myeloma. 320 / 0
2015-09-28
KMF CRC
203 【基礎研究】CYR61/CCN1 overexpression in the myeloma microenvironment is associated with superior survival and reduced bone disease. 314 / 0
2015-09-28
KMF CRC
202 【基礎研究】The sialyltransferase ST3GAL6 influences homing and survival in multiple myeloma. 299 / 0
2015-09-25
KMF CRC
201 【基礎研究】A critical role of autocrine sonic hedgehog signaling in human CD138+ myeloma cell survival and drug resistance. 276 / 0
2015-09-25
KMF CRC
200 【基礎研究】PRIMA-1Met induces myeloma cell death independent of p53 by impairing the GSH/ROS balance. 286 / 0
2015-09-25
KMF CRC
199 【基礎研究】Plasmacytomagenesis in Eμ-v-abl transgenic mice is accelerated when apoptosis is restrained. 312 / 0
2015-09-25
KMF CRC
198 【レビュー】How we manage autologous stem cell transplantation for patients with multiple myeloma. 254 / 0
2015-09-25
KMF CRC
197 【臨床研究】A phase 2 single-center study of carfilzomib 56 mg/m2 with or without low-dose dexamethasone in relapsed multiple myeloma. 293 / 0
2015-09-25
KMF CRC
196 【臨床研究】Trends in survival of patients with primary plasma cell leukemia: a population-based analysis. 281 / 0
2015-09-25
KMF CRC
195 【臨床研究】Phase 1 study of twice-weekly ixazomib, an oral proteasome inhibitor, in relapsed/refractory multiple myeloma patients. 309 / 0
2015-09-25
KMF CRC
194 【臨床研究】Phase 1 study of weekly dosing with the investigational oral proteasome inhibitor ixazomib in relapsed/refractory multiple myeloma. 330 / 0
2015-09-25
KMF CRC
全51件   1  2  3 次の20件>>